27490927|t|TLR and NLRP3 inflammasome - dependent innate immune responses to tumor-derived autophagosomes (DRibbles)
27490927|a|Autophagosomes derived from tumor cells, also referred to as defective ribosomal products in blebs (DRibbles), have been previously shown to stimulate potent T-cell responses and mediate tumor regression when used as therapeutic cancer vaccines in multiple preclinical cancer models. In this report, we investigated the underlining mechanisms by which DRibbles induced T-cell activation, particularly how DRibbles activated antigen-presenting cells (APCs). We found that DRibbles could induce a rapid differentiation of monocytes and DC precursor (pre-DC) cells into functional APCs. DRibbles triggered innate receptor signaling via Toll-like Receptors (TLR)-2, TLR4, TLR7, TLR8, and nucleotide-binding oligomerization domain-containing protein 2 (NOD2), but not TLR3, TLR5, or TLR9. DRibbles induced PBMCs to produce pro-inflammatory cytokines, such as IL-6, IL-10, TNF-α, and IL-1β. DRibbles induced IL-1β release from PBMC or THP-1 cells without LPS priming, but required the core machinery of NLRP3 inflammasomes. Active endocytosis was required for inflammasome activation and cross presentation, and blocking endosome acidification or the ER-associated degradation (ERAD) pathway resulted in opposite effects on these two processes. Our data show that DRibbles could induce strong innate immune responses via multiple pattern recognition receptors, and explain why DRibbles could function as excellent antigen carriers to induce adaptive immune responses to both tumor cells and viruses. In contrast to the well-established inhibitory effect of autophagy on the inflammasome activation of APCs, our study demonstrates that isolated autophagosomes (DRibbles) from antigen donor cells activate inflammasomes by providing first and second signals required for IL-1β production by PMBC.
27490927	0	3	TLR	T103	UMLS:C0670896
27490927	8	13	NLRP3	T103	UMLS:C1384660
27490927	14	26	inflammasome	T103	UMLS:C2936529
27490927	80	94	autophagosomes	T017	UMLS:C3887595
27490927	96	104	DRibbles	T017	UMLS:C3887595
27490927	106	120	Autophagosomes	T017	UMLS:C3887595
27490927	134	145	tumor cells	T017	UMLS:C0597032
27490927	167	195	defective ribosomal products	T017	UMLS:C3887595
27490927	199	204	blebs	T038	UMLS:C0005758
27490927	206	214	DRibbles	T017	UMLS:C3887595
27490927	264	270	T-cell	T017	UMLS:C0039194
27490927	271	280	responses	T038	UMLS:C0007613
27490927	335	350	cancer vaccines	T103	UMLS:C0376659
27490927	375	388	cancer models	T038	UMLS:C1516211
27490927	398	404	report	T170	UMLS:C0684224
27490927	458	466	DRibbles	T017	UMLS:C3887595
27490927	475	492	T-cell activation	T038	UMLS:C1155065
27490927	511	519	DRibbles	T017	UMLS:C3887595
27490927	520	529	activated	T038	UMLS:C1326120
27490927	530	554	antigen-presenting cells	T017	UMLS:C0003315
27490927	556	560	APCs	T017	UMLS:C0003315
27490927	577	585	DRibbles	T017	UMLS:C3887595
27490927	607	622	differentiation	T038	UMLS:C0007589
27490927	626	635	monocytes	T017	UMLS:C0026473
27490927	640	667	DC precursor (pre-DC) cells	T017	UMLS:C0003315
27490927	684	688	APCs	T017	UMLS:C0003315
27490927	690	698	DRibbles	T017	UMLS:C3887595
27490927	709	734	innate receptor signaling	T038	UMLS:C1514762
27490927	739	766	Toll-like Receptors (TLR)-2	T103	UMLS:C0754728
27490927	768	772	TLR4	T103	UMLS:C1411976
27490927	774	778	TLR7	T103	UMLS:C1579758
27490927	780	784	TLR8	T103	UMLS:C1579755
27490927	790	852	nucleotide-binding oligomerization domain-containing protein 2	T103	UMLS:C2698508
27490927	854	858	NOD2	T103	UMLS:C2698508
27490927	869	873	TLR3	T103	UMLS:C1534866
27490927	875	879	TLR5	T103	UMLS:C0966553
27490927	884	888	TLR9	T103	UMLS:C0963057
27490927	890	898	DRibbles	T017	UMLS:C3887595
27490927	907	912	PBMCs	T017	UMLS:C1321301
27490927	924	950	pro-inflammatory cytokines	T103	UMLS:C0079189
27490927	960	964	IL-6	T103	UMLS:C0021760
27490927	966	971	IL-10	T103	UMLS:C0085295
27490927	973	978	TNF-α	T103	UMLS:C1456820
27490927	984	989	IL-1β	T103	UMLS:C0021753
27490927	991	999	DRibbles	T017	UMLS:C3887595
27490927	1008	1013	IL-1β	T103	UMLS:C0021753
27490927	1027	1031	PBMC	T017	UMLS:C1321301
27490927	1035	1046	THP-1 cells	T017	UMLS:C0682523
27490927	1055	1058	LPS	T103	UMLS:C0023810
27490927	1085	1089	core	T082	UMLS:C0444669
27490927	1103	1122	NLRP3 inflammasomes	T017	UMLS:C3156614
27490927	1131	1142	endocytosis	T038	UMLS:C0014139
27490927	1160	1183	inflammasome activation	T038	UMLS:C3272080
27490927	1188	1206	cross presentation	T038	UMLS:C1257986
27490927	1221	1229	endosome	T017	UMLS:C0034850
27490927	1230	1243	acidification	T038	UMLS:C1522821
27490927	1251	1291	ER-associated degradation (ERAD) pathway	T038	UMLS:C4235027
27490927	1364	1372	DRibbles	T017	UMLS:C3887595
27490927	1430	1459	pattern recognition receptors	T103	UMLS:C1564907
27490927	1477	1485	DRibbles	T017	UMLS:C3887595
27490927	1514	1521	antigen	T103	UMLS:C0003320
27490927	1541	1566	adaptive immune responses	T038	UMLS:C1155229
27490927	1575	1586	tumor cells	T017	UMLS:C0597032
27490927	1591	1598	viruses	T005	UMLS:C0042776
27490927	1636	1653	inhibitory effect	T038	UMLS:C0007613
27490927	1657	1666	autophagy	T038	UMLS:C0004391
27490927	1674	1697	inflammasome activation	T038	UMLS:C3272080
27490927	1701	1705	APCs	T017	UMLS:C0003315
27490927	1711	1716	study	T062	UMLS:C2603343
27490927	1744	1758	autophagosomes	T017	UMLS:C3887595
27490927	1760	1768	DRibbles	T017	UMLS:C3887595
27490927	1775	1782	antigen	T103	UMLS:C0003320
27490927	1783	1794	donor cells	T017	UMLS:C0007634
27490927	1795	1817	activate inflammasomes	T038	UMLS:C3272080
27490927	1869	1874	IL-1β	T103	UMLS:C0021753
27490927	1889	1893	PMBC	T017	UMLS:C1321301